Lexology October 24, 2024
- New Jersey AG Matthew Platkin announced the adoption of new rules designed to promote greater transparency in prescription drug pricing.
- The new rules implement recently enacted legislation intended to control prescription costs by imposing registration, reporting, and compliance requirements on manufacturers, insurance carriers, wholesalers, and other entities, who will be required to provide the AG’s office with information about drugs with significant price increases or high launch prices.
- The AG’s...
Today's Sponsors
Today's Sponsor